IV-MarketIntelligence (Premium-2): Neuroanatomy of the Cerebral Cortex: Structure, Function, and Significance

Exploring the intricate layers, regions, and roles of the brain’s outermost structure in cognition, sensation, and behavior

  
Generate a summary of this article
Listen to this article
Beta

Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.

The cerebral cortex, often referred to as the “gray matter” of the brain, is a marvel of biological engineering. As the outermost layer of the cerebrum, it is responsible for many of the higher-order functions that define human experience, including perception, thought, language, and voluntary movement. Understanding the neuroanatomy of the cerebral cortex is essential for appreciating how the brain processes information and orchestrates complex behaviors.

The cerebral cortex is a thin, highly folded sheet of neural tissue that covers the two cerebral hemispheres. Despite being...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Market Intelligence

How To Decarbonize Pharma R&D

As the planet heats up and sea levels rise, the need to reduce carbon emissions is becoming ever more urgent. The life sciences industry is just one of many that are looking to cut the carbon it produces.

IV-MarketIntelligence (Premium-2): Neuroanatomy of the Cerebral Cortex: Structure, Function, and Significance

Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.

[Test]With 75 Pipeline Candidates, TIL Therapies Gain Momentum in Solid Tumor Space

 
• By Nabil

Tumor infiltrating lymphocyte therapies show promise for solid tumors, with a first FDA approval, but face manufacturing and access challenges as development continues.

In Search Of Rare Disease Treatments, Nonprofits Can Lead the Charge

 
• By David Wild

Nonprofits are finding new ways to address market gaps and develop treatments for rare diseases with little commercial attraction.

More from In Vivo

Clone Test Oncology’s Next Decade: The Therapies And Players Reshaping A $400bn Future - Clone

 
• By Edwin Elmhirst and Lucie Ellis-Taitt

Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.

In Vivo’s 2026 Rising Leaders-Part 1

 
• By Saba Afreen

The seventh annual edition of In Vivo’s Rising Leaders features entrepreneurs, academics, lawyers, regulators and innovators from around the globe, representing the forefront of creativity in health care.

XXXXtesting

 
• By Saba Afreen

XXXXtesting